Codman & Shurtleff, a Johnson & Johnson company, will have its surgical instrumentation line integrated with Symmetry’s current hospital direct business. The business line will be named Symmetry Surgical and is expected to produce more than $100 million in annual sales.
Related Articles on Orthopedic Devices:
Orthopedic Researchers Discover New Factor in Metal on Metal Hip Implant Design
RoG Sports Medicine Receives FDA Clearance for Suture Anchor
International Consortium of Orthopaedic Registries Reports on Progress
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
